Both in Pharmaceuticals
Ardelyx vs Aktis Oncology
Over the past year ARDX returned −60.1% and AKTS returned −32.8%; their daily moves had a correlation of 0.15.
ARDX −60.1% AKTS −32.8%Growth of $1, one year, split-adjusted
| Metric | ARDX | AKTS |
|---|---|---|
| Price | $3.09 | $15.06 |
| Market cap | $797.8M | $837.6M |
| Today | −5.50% | −5.93% |
| 1 month | −8.6% | −34.1% |
| 6 months | −52.1% | −25.6% |
| Year to date | −47.0% | — |
| 1 year | −39.8% | — |
| Revenue growth (YoY) | +23.8% | — |
| Gross margin | 95.2% | 100.0% |
| Net margin | −13.8% | −713.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | — |
| Net cash | $30.0M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 49.7% | 50.1% |
| Short % of float | 11.4% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).